SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Contingent Liabilities | ₹85 Cr | ₹85 Cr | ₹84 Cr | ₹84 Cr |
What is the latest Contingent Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹85 Cr |
| Mar2025 | ₹85 Cr |
| Mar2024 | ₹84 Cr |
| Mar2023 | ₹84 Cr |
How is Contingent Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹85 Cr | -0.06 | |
| Mar2025 | ₹85 Cr | 1.47 | |
| Mar2024 | ₹84 Cr | 0.00 | |
| Mar2023 | ₹84 Cr | - | |
Compare Contingent Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹6,911.9 Cr | -0.6% | -9.2% | 32.8% | Stock Analytics | |
| PRIME FOCUS | ₹23,970.3 Cr | 7.9% | 39.4% | 78% | Stock Analytics | |
| SAGILITY | ₹21,000.4 Cr | 8.6% | 13.8% | -0.8% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹16,697.8 Cr | 2.7% | -5.9% | -39.5% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹14,995.9 Cr | 0.4% | -2.5% | -16.8% | Stock Analytics | |
| INDEGENE | ₹12,614.8 Cr | 7.2% | -0.4% | -7.7% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -0.6% |
-9.2% |
32.8% |
| SENSEX | 1.2% |
1.2% |
-5.5% |
You may also like the below Video Courses